ArticleEndocrine connections2025
The combined diagnostic and therapeutic value of ultrasound and X-ray bone age index in girls with idiopathic central precocious puberty.
Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Role of Pelvic Ultrasound in Monitoring and Predicting Therapeutic Efficacy of GnRHa for Central Precocious Puberty.Journal of clinical ultrasound : JCU · 2026Article
- Uterine artery pulsatility index as a functional biomarker of central precocious puberty: a scoping review.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The objectives of this study are threefold: first, to evaluate the diagnostic utility of ultrasound in combination with radiographic bone age assessments for identifying idiopathic central precocious puberty (ICPP) in girls; second, to determine the efficacy of treatment; and third, to establish comprehensive models for both diagnosis and therapeutic evaluation. Methods: Female patients diagnosed with 96 cases of ICPP in our hospital from January 2022 to February 2024 were assigned to the research group, while 94 girls with premature thelarche from the same period were designated as the control group. Both groups underwent ultrasound examinations (of the uterus, ovaries, and breasts) and X-ray bone age evaluations, and their serum endocrine hormone levels (luteinizing hormone and follicle-stimulating hormone) were measured. Differences in ultrasound parameters, bone age indices, and hormone levels were analyzed between the research and control groups. Univariate and multivariate LASSO regression were employed to screen imaging parameters, and a LASSO-logistic regression model was established to create a combined predictive model. Receiver operating characteristic curves were plotted to investigate the diagnostic efficacy of the individual and combined models in ICPP. The general clinical data and imaging parameters of the ICPP group were compared before and after treatment, with ultrasound and bone age indices used in combination to assess therapeutic efficacy. Results: The LASSO regression screened important predictive indicators, including the bone age index (BAI), mean bilateral breast thickness, uterine longitudinal diameter, uterine anteroposterior diameter, uterine transverse diameter, endometrial thickness, mean bilateral ovarian length, and the mean number of ovarian follicles with a diameter >4 mm. These imaging parameters were incorporated into a logistic regression model, which demonstrated good discriminatory power with an AUC value of 0.895 (95% CI: 0.851, 0.938). The combined model outperformed the model using ultrasound alone (AUC: 0.869 (95% CI: 0.820, 0.918)) and the BAI model (AUC: 0.758 (95% CI: 0.690, 0.826)), showing superior discrimination and calibration. In the follow-up evaluation of the ICPP group post-treatment, ultrasound parameters such as uterine anteroposterior diameter, mean bilateral ovarian length, mean number of ovarian follicles with a diameter >4 mm, mean maximum follicular diameter, and mean bilateral ovarian volume showed good monitoring efficacy (AUC >0.7). In addition, the uterine longitudinal diameter and BAI exhibited high specificity. Together, these indicators achieved a combined diagnostic AUC value of 0.877 with 75% sensitivity and 87% specificity. Conclusions: To enhance diagnostic precision and overcome the constraints of single-metric evaluation approaches, a composite model was constructed by integrating ultrasound-based parameters with radiographic bone age measurements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.